Psoriasis Action Month: Immune-Mediated Dermatologic Conditions and COVID-19 Illness

August marks the beginning of Psoriasis Action Month, an observance organized by the National Psoriasis Foundation which aims to support patients with the common skin condition while promoting awareness and furthering efforts to find a cure for psoriatic disease. While the coronavirus continues to evolve and research efforts attempt to keep up with its changing manifestations, […]

Botulinum Toxin for Psoriasis Treatment

Prior research has demonstrated that neurotransmitters may play a role in the pathogenesis of numerous cutaneous conditions, including psoriasis, revealing the close connection between the skin and the central nervous system. Reports have even shown that psoriasis symptoms can improve after peripheral nervous system injury. As such, there is promising potential for neuromodulators, such as […]

Black History Month: Addressing the Historic Lack of African-American Patients in Psoriasis Trials

Although psoriasis affects people of all skin colors, current estimates reveal that most racial and ethnic marginalized populations are often lacking in psoriasis research clinical trials. While the skin condition affects approximately 4% of Caucasians, 2% of African Americans, 1.6% of Hispanics, and approximately 0.47% of Asians, an overwhelming majority of psoriasis patients taking part […]

Tape Strip Diagnostic Testing for Eczema and Psoriasis Biomarkers 

The current understanding of atopic dermatitis pathophysiology is primarily derived from skin biopsy studies – a diagnostic technique that may cause scarring and is impractical in large-scale clinical studies. Tape strips, on the other hand, promise a minimally invasive technique of accurately detecting distinct immune and barrier markers of atopic dermatitis and psoriasis. This method […]

The Connection Between Dietary Factors and Psoriasis 

Today, it is estimated that psoriasis affects up to 125 million people worldwide. Treating and managing the condition is primarily focused on reducing the severity and recurrence of flare-ups, alleviating discomfort, and improving patient quality of life. While topical medications, such as corticosteroids, and biologics are the primary lines of psoriasis treatment and disease management […]

Psoriasis and Low Dose Naltrexone

Psoriasis is a common skin disease affecting 2 to 3 percent of the world population.1 It occurs equally in men and women and can appear at any age. There are several patterns of psoriasis, some more devastating than others: Chronic plaque psoriasis, which is the most common type, this usually presents on the knees, elbows, […]

Psoriasis Awareness Month: Emerging Topical Treatment for Chronic Plaque Psoriasis

August marks the beginning of Psoriasis Awareness Month, during which healthcare organizations such as LivDerm and the National Psoriasis Foundation bring attention to the common yet underappreciated skin disorder. Often triggered by stress, infections, and medications, the chronic inflammatory condition affects up to 125 million patients worldwide and has been linked to decreased quality of life […]

Growing Evidence of Increased Cancer Risk in Psoriasis Patients

Often triggered by stress, infections, and certain medications, the chronic inflammatory skin condition psoriasis affects up to 125 million patients worldwide. The skin disorder has been linked to decreased quality of life, along with an increased risk of comorbid conditions. In recent years, the association between psoriasis and risk of cancer has been controversial with […]

The Role of Gut Microbiome in Psoriasis

The body of clinical literature concerning psoriasis is continuously growing as the disease’s many unsolved mysteries continue to puzzle investigators. While research has yet to uncover a cure for psoriasis, significant developments in recent years have enabled the development of therapies that can drastically mitigate associated symptoms and improve patient quality of life. A new […]

The Future of the Atopic Dermatitis Market

Although sometimes conflated as one condition, psoriasis and atopic dermatitis (AD) differ from each other in clinical presentation yet share similar guidelines, mental health repercussions, and therapeutic options. As psoriasis-focused treatment modalities have multiplied over the past few years due to a spike in prevalence, similar growth is currently being witnessed in the AD medication […]